Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical Cancer Recurrent or Persistent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00057928
What this trial is testing

S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)WithdrawnNCT05998941
What this trial is testing

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT02172911
What this trial is testing

INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer

Who this might be right for
Cervical Cancer
Inovio Pharmaceuticals 10
Not applicableEnded earlyNCT00639405
What this trial is testing

Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas

Who this might be right for
Parathyroid NeoplasmParathyroid Diseases
State University of New York - Upstate Medical University 12
Large-scale testing (Phase 3)Study completedNCT00003945
What this trial is testing

Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 400
Testing effectiveness (Phase 2)Study completedNCT03816553
What this trial is testing

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical Cancer
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Early research (Phase 1)WithdrawnNCT02312804
What this trial is testing

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Who this might be right for
Cancer of CervixTumors
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Study completedNCT03635567
What this trial is testing

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 617
Large-scale testing (Phase 3)Looking for participantsNCT05798819
What this trial is testing

GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 424
Testing effectiveness (Phase 2)Study completedNCT00016926
What this trial is testing

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Study completedNCT00803062
What this trial is testing

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 452
Testing effectiveness (Phase 2)UnknownNCT00826891
What this trial is testing

Study of Cisplatin in Cervical Cancer Stage IVB

Who this might be right for
Cervical Cancer
Chinese Anti-Cancer Association 40
Testing effectiveness (Phase 2)Ended earlyNCT04230954
What this trial is testing

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer+1 more
University of South Alabama 5
Not applicableActive Not RecruitingNCT01051895
What this trial is testing

Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers

Who this might be right for
High Grade Cervical Intra-epithelial Neoplasia
Centre hospitalier de l'Université de Montréal (CHUM) 2,253
Testing effectiveness (Phase 2)Ended earlyNCT00030472
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT04974944
What this trial is testing

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Who this might be right for
Stage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
Sun Yat-Sen University Cancer Center 35
Testing effectiveness (Phase 2)UnknownNCT05824494
What this trial is testing

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Who this might be right for
Uterine Cervical NeoplasmsCancer of CervixCervical Cancer+3 more
Women's Hospital School Of Medicine Zhejiang University 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03614949
What this trial is testing

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerCervical Cancer RecurrentCervical Cancer Metastatic
H. Lee Moffitt Cancer Center and Research Institute 21
Large-scale testing (Phase 3)Looking for participantsNCT06123884
What this trial is testing

BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer

Who this might be right for
Cervical Cancer
Bio-Thera Solutions 526
Next Page